The Kraft Heinz Company has confirmed plans to sell Italian Baby and Specialty Food business to Italy’s NewPrinces Group.
The deal, announced today, will see the departure of infant food brands Plasmon, Nipiol and Dieterba, and specialty food brands Aproten and Biaglut.
It also includes the purchase of Kraft Heinz’s production facility in Latina, Italy. The factory employs around 300 people and produces approximately 1.8bn biscuits per year for Plasmon. NewPrinces has confirmed all jobs are safe and the factory will continue to operate business as usual, following completion of the sale.
“This marks an important milestone in driving our strategy across Europe and the Pacific, enabling us to fuel investment and growth in our core areas, and enhance focus on our Accelerate platforms,” says Willem Brandt, president of Europe and Pacific Developed Markets at Kraft Heinz. “It’s a great example of how we’re intentionally and proactively managing our portfolio to accelerate organic growth and drive sustainable, long-term value.”
The move is part of the multinational’s strategy to focus on “driving profitable growth” through its Accelerate platforms, which include its tomato ketchups, mayonnaises, table sauces, and pasta sauces.
“I’m confident this portfolio of iconic brands will thrive in the capable hands of the NewPrinces Group – a market leader in the food and beverage industry, including in specialised nutrition, with a strong Italian heritage and ambitious growth plans,” says Carmela Bazzarelli, managing director of Kraft Heinz Italia. “We remain committed to Italy and growing our iconic Heinz brand across the country.”
The NewPrinces Group is a specialised food and beverage company, with a global supply network offering a wide range of branded and private label products across the UK and Europe. Formerly known as Newlat Food, the Group was rebranded as NewPrinces Group following its acquisition of Princes Limited in 2024. Its portfolio includes Princes, Napolina, Delverde, Branston (beans), sunflower oil brand Flora, and more.
The deal, currently awaiting regulatory approval, is expected to be completed by the end of the year. And, as yet, both companies remain tight-lipped on its value.
